ACRS Insider Holders & Insider Ownership - Aclaris Therapeutics Inc.

List of insiders holdings for Aclaris Therapeutics Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

#	Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
1	Leonard Braden Michael 10% Owner	2024-08-05 15:57:34	0 14,250,000	14,250,000	Form 4
2	Biosion Inc. 10% Owner	2024-11-25 11:03:18	11,281,985 0	11,281,985	Form 3
3	Foresite Capital Management III LLC Foresite Capital Fund III L.P. Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner	2022-02-11 15:12:53	4,657,277 0	4,657,277	Form 13G
4	VIVO VENTURES VII LLC Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. 10% Owner	2019-02-14 15:35:52	1,647,214 0	1,647,214	Form 13D
5	Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES AKKARAJU SRINIVAS POWELL MICHAEL 10% Owner	2018-02-14 13:58:26	1,552,112 0	1,552,112	Form 13D
6	Walker Neal CEO	2025-04-03 16:15:20	1,482,799 0	1,482,799	Form 4
7	Mehra Anand Director	2024-11-20 16:20:04	710,030 0	710,030	Form 4
8	Tullman Stephen A. Director	2018-10-05 16:37:31	177,457 394,014	571,471	Form 4
9	Loerop James Chief Business Officer	2025-02-04 16:15:08	549,606 0	549,606	Form 4
10	Davis Hugh M. President and COO	2025-02-04 16:15:17	336,300 0	336,300	Form 4
11	Powala Christopher Chief Reg & Develop Officer	2019-02-05 18:33:25	151,929 130,434	282,363	Form 4
12	Monahan Joseph Chief Scientific Officer	2025-03-04 16:15:14	276,587 193	276,780	Form 4
13	FMR LLC See Remark 1	2020-02-07 11:12:21	205,984 0	205,984	Form 13G
14	Ruffo Frank Chief Financial Officer	2022-03-14 16:56:19	201,883 0	201,883	Form 4
15	Ali-Jackson Kamil Chief Legal Officer	2022-01-05 16:33:56	160,214 0	160,214	Form 4
16	Gordon David N. Chief Medical Officer	2021-07-14 17:32:17	147,447 0	147,447	Form 4
17	Manion Douglas J. Pres and CEO	2024-01-03 16:44:56	122,813 0	122,813	Form 4
18	Balthaser Kevin Chief Financial Officer	2025-03-04 16:15:22	94,983 0	94,983	Form 4
19	Shanler Stuart Chief Scientific Officer	2019-03-04 18:09:26	82,200 0	82,200	Form 4
20	Cawkwell Gail Chief Medical Officer	2023-07-05 16:23:25	54,593 0	54,593	Form 4
21	Powell Andrew Kenneth William Director	2024-06-04 16:30:21	33,523 0	33,523	Form 4
22	Reasons Bryan M. Director	2024-06-04 16:30:22	28,732 0	28,732	Form 4
23	Fair Brett Chief Commercial Officer	2019-02-05 18:30:05	22,207 0	22,207	Form 4
24	SCHIFF ANDREW N Director	2024-06-10 16:15:14	20,543 0	20,543	Form 4
25	GOWEN MAXINE Director	2024-06-10 16:15:16	20,543 0	20,543	Form 4
26	Molineaux Christopher P. Director	2024-06-10 16:15:17	20,543 0	20,543	Form 4
27	MILANO VINCENT Director	2024-06-10 16:15:18	20,543 0	20,543	Form 4
28	Humphries William D. Director	2024-06-10 16:15:21	20,543 0	20,543	Form 4
29	Bierly Rick Director	2017-06-16 19:46:58	8,000 0	8,000	Form 4
30	CHA ALBERT Director	2016-07-01 16:17:17	6,632 0	6,632	Form 4
31	Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner	2020-02-13 12:36:57	0 0	0	Form 13G
32	RA CAPITAL MANAGEMENT LLC Kolchinsky Peter RA Capital Healthcare Fund LP 10% Owner	2024-02-14 17:01:20	0 0	0	Form 13G

Insider Holders & Insider Ownership - Aclaris Therapeutics Inc. (ACRS)